The Managed Care Oncology Index (MCOI) is the largest and longest running quantitative report focused on issues of access to various cancer therapies. It is a syndicated report based on quarterly multi-stakeholder surveys and is meant to provide a comprehensive view of the current and anticipated impact of various market dynamics across multiple oncology and supportive care therapies.
Make informed and smart strategy recommendations with robust, market-representative research on oncology therapies
Estimate multi-stakeholder clinical value perception and anticipated adoption of upcoming pipeline agents
Use a combination of quantitative and qualitative insights to design techniques ensuring your brand’s competitiveness in categories expanding with new agents
Bridge the gap between custom and syndicated research by providing input into surveys and receiving a tailored view of the syndicated findings
Develop Payer profiles to predict future policy development and management changes
This syndicated report is customizable to the requirements of various departments. Additionally, the service-based model of this product ensures not just actionable data, but the accompanying expertise of our team to help your organization with informed strategic decisions.We offer two syndicated studies of specialty pharmacy customers, tailored for different professional audiences. The surveys provide objective, comparative and third-party assessments of all major specialty pharmacies and monitor their ongoing performance to help both drug manufacturers and the specialty pharmacy industry better understand the patient experience.